Head-to-head dispatch
AbundRX vs Queen RX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
AbundRX (Abundant Wellness) advertises the lowest headline figures in its peer group — $99 and $149 — and states nowhere on the site what those figures are charged per.
$99 to start (the site states no billing cycle for it anywhere, compounded) sema · $149 to start (the site states no billing cycle for it anywhere, compounded) tirz · Verified August 29, 2026
Marked down on: ⛔ No billing cycle anywhere on the site. Both cards say 'Starting at $99' and 'Starting at $149' with no 'per month', no 'first order' and no 'per vial', so a reader cannot compare the figure to anything
Desk Score
Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).
$100/mo (quarterly plan, compounded) sema · Verified July 20, 2026
Marked down on: No LegitScript or PCAB accreditation
Queen RX takes this head-to-head with the higher Desk Score, 74/100 (C) against 58/100 (C) for AbundRX. AbundRX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
AbundRX
58/100
C
Queen RX
74/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | AbundRX | Queen RX |
|---|---|---|
| Semaglutide | $99 to start (the site states no billing cycle for it anywhere, compounded) | $100/mo (quarterly plan, compounded) |
| Tirzepatide | $149 to start (the site states no billing cycle for it anywhere, compounded) | Not listed on Queen RX's site (checked July 20, 2026) |
| Coverage | Not listed on AbundRX's site (checked August 29, 2026) | 45 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Nobody, until the site states a billing cycle: several sellers publish a full term ladder, name their pharmacies and post a working refund policy for the same money. | Budget-conscious patients seeking low-cost compounded GLP-1. |
| Desk Score | 58/100C | 74/100C |
The verdict
Desk pick — Queen RXQueen RX takes this head-to-head with the higher Desk Score, 74/100 (C) against 58/100 (C) for AbundRX. AbundRX still holds its ground where its strengths line up with yours.
Choose AbundRX if…
Nobody, until the site states a billing cycle: several sellers publish a full term ladder, name their pharmacies and post a working refund policy for the same money.
$99 to start (the site states no billing cycle for it anywhere, compounded) sema · $149 to start (the site states no billing cycle for it anywhere, compounded) tirz
Choose Queen RX if…
Budget-conscious patients seeking low-cost compounded GLP-1.
$100/mo (quarterly plan, compounded) sema · 45 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: AbundRX · Queen RX.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- AbundRX vs CoreAge Rx
- CoreAge Rx vs Queen RX
- AbundRX vs Vytora Health
- Queen RX vs Sunlight
- AbundRX vs Sunlight
- EverSlim vs Queen RX
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.